We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Product Update.
- Authors
Burger, Valerie
- Abstract
The article presents updates on cancer drugs. Dexrazoxane hydrochloride for injection, Totect™ from TopoTarget, was approved by the U.S. Food and Drug Administration, for the treatment of extravasation resulting from IV anthracycline chemotherapy. New safety-related product-labeling changes for the erythropoiesis-stimulating agents (ESA) Epogen™, epoetin alfa from Amgen Inc. was approved by the FDA. Topotecan, Hycamtin® from GlaxoSmithKline, capsules for the treatment of relapsed small cell lung cancer (SLCS) was approved by the FDA.
- Subjects
UNITED States; CANCER treatment; DRUGS; TOPOTARGET A/S; UNITED States. Food &; Drug Administration; ANTHRACYCLINES
- Publication
Oncology Nursing Forum, 2008, Vol 35, Issue 2, p283
- ISSN
0190-535X
- Publication type
Article
- DOI
10.1188/08.ONF.283-285